Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?

Two international multicentre randomised controlled trials of drotrecogin alfa (activated) (DrotAA), the Recombinant Human Activated Protein C Worldwide Evaluation of Severe Sepsis (PROWESS) and Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) trials, have produc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Friedrich, Jan O, Adhikari, Neill KJ, Meade, Maureen O
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2006
Fag:
Commentary
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1550958/
https://ncbi.nlm.nih.gov/pubmed/16762040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc4947
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker